@MaorHalfon They need to raise cash. This is out of the question.
Just sit back and watch, only delay I see is specialized funds not wanting to pay these absurd prices.
I have no idea where the top is, I have sized my short to have ample room for $MRNA to run
But I suspect when it inevitably loses momentum it will collapse hard with AI degens getting margin called as usual
@TranslucideUS Also, if needed I’m sure they can put grouting cash flows on a trust and use that as collateral on a loan for expansion capex (if they were to need any)
I really don’t see dilution in the horizon.
My concern also, a 30 usd offer would probably leave most shareholders extatic while seriously undervaluing $PESI
I guess we need to wait for some old shareholders capital to rotate before we can go up.
So, I’m getting questions on $PESI today. I always do when the price is down. What I would say is with the award in hand the chief worry with current price action is that $PESI is acquired by one of the many larger players in its field. There is now a massive bullseye on $PESI
@Piotrek0790210@VelvetYammer They diluted in May for this purpose.
The CEO was explicitly saying there are simple upgrades needed in the call. Check the transcript.
I would really appreciate someone provide me with a bearish view on $PESI
Why is this not a high 40s, low 50s stock (on the lower end)?
Just to confirm I’m staying rational